🇺🇸 FDA
Pipeline program

AL (Coartem)

20/CNBS/22

Approved small_molecule completed

Quick answer

AL (Coartem) for Malaria is a Approved program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Malaria
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials